Lifeway opposes dissident director nominees citing ethical concerns
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil settles up 2% after Trump rejects return to Iran ceasefire deal terms
- Could SpaceX's orbital compute avoid the political headwinds facing data centers?
- Could Meta's teen settlement be less painful than feared? Citi weighs in
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- First Financial to acquire Hickory Point Bank in $111.3M deal
- Revolution Medicines prices RASONQUE at $39,800 per month
Lifeway Issues Letter to Shareholders Regarding Dissident Director Nominees, Revealing Disqualifying Track Records and Ethical Failures
December 2, 2025 11:38 AM ESTHighly concerning nominee backgrounds underscore questionable judgement by Edward Smolyansky and George Sent, Managing Director of Cascadia Capital
Edward and Ludmila Smolyanskys personal liquidity needs may be behind their demands for a quick sale of Lifeway at any price
MORTON GROVE, Ill., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Lifeway Foods, Inc. (NASDAQ: LWAY) (Lifeway or the Company), a leading U.S. supplier of kefir and fermented probiotic products, today issued the following statement in response to Edward Smolyanskys (the Dissident) intent to nominate George Sent, Managing Director... More
